DB
ONC

Dmitry Balyasny’s BeOne Medicines Ltd ONC Stock Holding History

Dmitry Balyasny’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,503
Closed -$446K – 3602
2026
Q1 		$446K Buy
+1,503
New +$487K ﹤0.01% 2411
2025
Q2 		– Sell
-9,064
Closed -$2.47M – 3484
2025
Q1 		$2.47M Sell
9,064
-35,229
-80% -$8.24M ﹤0.01% 1609
2024
Q4 		$8.18M Buy
+44,293
New +$9.05M 0.01% 1046
2024
Q2 		– Sell
-5,120
Closed -$801K – 3215
2024
Q1 		$801K Buy
+5,120
New +$824K ﹤0.01% 1880

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Dmitry Balyasny's ONC Position: Q2 2026 in Review

Dmitry Balyasny sold out of BeOne Medicines Ltd (ONC) in Q2 2026, closing a stake of 1,503 shares — an estimated $446K sold.

Dmitry Balyasny first reported a position in ONC in Q1 2024 and held it in 4 quarters. The position peaked at $8.18M in Q4 2024. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Dmitry Balyasny reported no remaining BeOne Medicines Ltd position as of Q2 2026 after selling out during the quarter.
  • Dmitry Balyasny sold 1,503 BeOne Medicines Ltd shares in Q2 2026, an estimated $446K.
  • Dmitry Balyasny first reported a position in BeOne Medicines Ltd in Q1 2024 and held it in 4 quarters.
  • Dmitry Balyasny's BeOne Medicines Ltd position peaked at $8.18M in Q4 2024.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.